Solvonis Therapeutics AI Stock Analysis
Solvonis Therapeutics (J4I) AI Stock Analysis
Solvonis Therapeutics
(Frankfurt:J4I)
No summary available
Solvonis Therapeutics (J4I) vs. iShares MSCI Germany ETF (EWG)
Not enough price history over this period.
- Market Cap
- EUR 6.13M
- Dividend Yield
- ―
- Average Volume (3M)
- ―
- Price to Earnings (P/E)
- -1.1
- Beta (1Y)
- -2.13
- Revenue Growth
- ―
- EPS Growth
- ―
- Country
- Germany
- Employees
- 6
- Sector
- Industrials
- Sector Strength
- 63
- Industry
- Biotechnology
Solvonis Therapeutics Business Overview & Revenue Model
Company Description
Solvonis Therapeutics PLC focuses on the development of therapeutic solutions. The company is engaged in the development of novel small-molecule therapeutics for high-burden central nervous system ("CNS") disorders focusing on addiction and psychiatr...
Solvonis Therapeutics Peers Comparison
Overall Rating
GB:IMI70Outperform
GB:AVG62Neutral
GB:SMIN61Neutral
GB:MGAM58Neutral
GB:MPAC45Neutral
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| 70Outperform | GBP 6.76B | 21.28 | 32.41% | 1.21% | 7.67% | 45.97% | |
| Sector * | 63Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% |
| 62Neutral | GBP 280.68M | 38.38 | 5.57% | 0.67% | 4.43% | 2.67% | |
| 61Neutral | GBP 7.31B | 4.28 | 92.97% | 2.29% | -33.55% | 4.29% | |
| 58Neutral | GBP 743.56M | 40.39 | 5.79% | 4.54% | -5.58% | -32.73% | |
| 45Neutral | GBP 103.00M | -13.88 | -10.45% | ― | 9.04% | 40.78% |
* Industrials Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| DE:J4I | Solvonis Therapeutics plc | ― | ― | ― | |
| GB:AVG | Avingtrans plc | 760.00 | 253.62 | 50.08% | |
| GB:IMI | IMI plc | 2916.00 | 512.76 | 21.34% | |
| GB:MPAC | Mpac Group PLC | 342.50 | -7.50 | -2.14% | |
| GB:MGAM | Morgan Advanced Materials | 269.00 | 83.16 | 44.75% | |
| GB:SMIN | Smiths Group plc | 2692.00 | 273.64 | 11.32% |
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
